Cover Image
市場調查報告書

全球培養3D細胞市場:成長,趨勢,預測

Global 3D Cell Culture Market - Segmented by Technology, Application and End-User - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 391456
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球培養3D細胞市場:成長,趨勢,預測 Global 3D Cell Culture Market - Segmented by Technology, Application and End-User - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 106 Pages
簡介

本報告提供全球培養3D細胞市場相關調查,市場概要和各技術,各用途,各終端用戶,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 波特五力分析

第6章 促進要素,阻礙要素,機會,課題分析

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各技術
    • 細胞外矩陣
    • 生物反應器
    • 凝膠
    • 無支架平台
    • 微晶片
    • 其他
  • 各用途
    • 研究
    • 藥物研發
    • 組織工程
    • 臨床
    • 幹細胞生物學
    • 其他
  • 各終端用戶
    • 研究實驗室、研究機關
    • 生物科技企業、製藥產業
    • 醫院、診斷中心
    • 其他

第8章 各地區佔有率與預測

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第9章 競爭環境

  • 合併、收購分析
  • 新產品上市
  • 協定,聯合,聯盟

第10章 企業簡介

第11章 投資的機會相關分析師的見解

第12章 市場未來的預測

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 33111

The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries.

Rising Need for Organ Transplantation

Cell culture is a process to grow prokaryotic cells or eukaryotic cells artificially, outside their natural environment, in a laboratory under controlled conditions. During the last decade, the demand for organ transplantation has increased, worldwide, due to increased incidences of organ failure, rise in success and improvement in post-transplant outcome. Increasing healthcare costs, aging population and rising prevalence of chronic disease that will continue to shape the industrial life science and thus majority of life science companies are investing in R&D sector.

Additionally, development of automated large-scale cell culture systems, use of 3D cell culture models, as an alternative tool in vivo testing and increasing focus on the regenerative medicine is also acting as a driver for Global 3D Cell Culture Market.

Budget Restriction for Small and Medium Sized Laboratories

3D hydrogels in cell culture market face challenges that have been hindering the market growth over the years. There hindrances include financial challenges by small & medium biotechnology and pharmaceutical companies. The initial investment, associated with 3D hydrogels in cell culture, is high. Moreover, organizations, operating at small or medium scale, are unable to bear the expenditure. This factor is the major restraint to the market growth. The application in developing countries of new biotechnology in cell culture and others areas will result in demand of experienced and skilled professionals and thus lack of skilled professionals for the 3D cell culture is also restraining the growth of 3D Cell Culture Market.

In addition, lack of consistency in 3D Cell Culture Products and Stringent Process Controls for advanced handling capabilities is also hindering the market.

North America to Dominate the Market

The market has been segmented on the basis of technology, application, end-user, and geography. Based on technology, the market has been segmented into extracellular matrices (scaffolds), bioreactors, gels, scaffold-free platforms, microchips, and others. The market, based on application, has been divided into research, drug discovery, tissue engineering, clinical applications, stem cell biology, and others. On the basis of end user, the market has been segregated into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers, and others. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the 3D Cell Culture market due to the due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries which are investing in the R&D projects carried out which results in the high demand in that region.

Key Developments in the Market

October 2017: A partnership between Insphero AG and Charles River Laboratories International Inc.

May 2017: 3D Biotek got FDA approval for 3D Cell Expansion System (3D-CES) as a medical device.

Key Players: 3D BIOMATRIX, REINNERVATE LTD, 3D BIOTEK LLC, BECTON DICKINSON AND COMPANY, SIGMA ALDRICH CORPORATION, CORNING INCORPORATED, THERMO FISHER SCIENTIFIC, GLOBAL CELL SOLUTIONS INC., NANOFIBER SOLUTIONS INCORPORATION, INSPHERO AG, LONZA GROUP, NANO 3D BIOSCIENCES.

REASONS TO PURCHASE THIS REPORT

Current and future Global 3D Cell Culture Market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet in excel.

CUSTOMIZATION OF THE REPORT

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. INTRODUCTION

  • 1.1 MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW

  • 5.1 CURRENT MARKET SCENARIO
  • 5.2 PORTERS FIVE FORCES
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF CONSUMERS
    • 5.2.3 THREATS OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
    • 5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • 6.1 MARKET DRIVERS
    • 6.1.1 HUGE INVESTMENT BY LIFE SCIENCE COMPANIES FOR R&D
    • 6.1.2 DEVELOPMENT OF AUTOMATED LARGE-SCALE CELL CULTURE SYSTEMS
    • 6.1.3 RISE IN RESEARCH AND DEVELOPMENT INVESTMENTS
    • 6.1.4 RISING NEED FOR ORGAN TRANSPLANTATION
    • 6.1.5 USE OF 3D CELL CULTURE MODELS AS AN ALTERNATIVE TOOL FOR INVIVO TESTING
    • 6.1.6 INCREASING FOCUS ON REGENERATIVE MEDICINE
  • 6.2 MARKET RESTRAINT
    • 6.2.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS
    • 6.2.2 BUDGET RESTRICTION FOR SMALL AND MEDIUM SIZED LABORATORIES
    • 6.2.3 LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS
    • 6.2.4 STRINGENT PROCESS CONTROLS FOR ADVANCED HANDLING CAPABILITIES
  • 6.3 OPPORTUNITIES
  • 6.4 KEY CHALLENGES

7. MARKET SEGMENTATION

  • 7.1 BY TECHNOLOGY
    • 7.1.1 EXTRACELLULAR MATRICES (SCAFFOLDS)
    • 7.1.2 BIOREACTORS
    • 7.1.3 GELS
    • 7.1.4 SCAFFOLD-FREE PLATFORMS
    • 7.1.5 MICROCHIPS
    • 7.1.6 OTHERS
  • 7.2 BY APPLICATION
    • 7.2.1 RESEARCH
    • 7.2.2 DRUG DISCOVERY
    • 7.2.3 TISSUE ENGINEERING
    • 7.2.4 CLINICAL APPLICATIONS
    • 7.2.5 STEM CELL BIOLOGY
    • 7.2.6 OTHERS
  • 7.3 BY END USER
    • 7.3.1 RESEARCH LABORATORIES AND INSTITUTES
    • 7.3.2 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
    • 7.3.3 HOSPITALS AND DIAGNOSTIC CENTERS
    • 7.3.4 OTHERS
  • 7.4 SEGEMENTATION BY GEOGRAPHY
    • 7.4.1 NORTH AMERICA
      • 7.4.1.1 UNITED STATES
      • 7.4.1.2 CANADA
      • 7.4.1.3 MEXICO
    • 7.4.2 EUROPE
      • 7.4.2.1 FRANCE
      • 7.4.2.2 GERMANY
      • 7.4.2.3 UNITED KINGDOM
      • 7.4.2.4 ITALY
      • 7.4.2.5 SPAIN
      • 7.4.2.6 REST OF EUROPE
    • 7.4.3 ASIA-PACIFIC
      • 7.4.3.1 CHINA
      • 7.4.3.2 JAPAN
      • 7.4.3.3 INDIA
      • 7.4.3.4 AUSTRALIA & NEW ZEALAND
      • 7.4.3.5 SOUTH KOREA
      • 7.4.3.6 REST OF ASIA-PACIFIC
    • 7.4.4 MIDDLE EAST AND AFRICA
      • 7.4.4.1 GCC
      • 7.4.4.2 SOUTH AFRICA
      • 7.4.4.3 REST OF MIDDLE EAST AND AFRICA
    • 7.4.5 SOUTH AMERICA
      • 7.4.5.1 BRAZIL
      • 7.4.5.2 ARGENTINA
      • 7.4.5.3 REST OF SOUTH AMERICA

8. COMPETITIVE LANDSCAPE

  • 8.1 MERGERS AND ACQUISITION ANALYSIS
  • 8.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
  • 8.3 NEW PRODUCTS LAUNCHES

9. COMPANY PROFILES

  • 9.1 3D BIOMATRIX
  • 9.2 REINNERVATE LTD
  • 9.3 3D BIOTEK LLC
  • 9.4 BECTON DICKINSON AND COMPANY
  • 9.5 SIGMA ALDRICH CORPORATION
  • 9.6 CORNING INCORPORATED
  • 9.7 THERMO FISHER SCIENTIFIC
  • 9.8 GLOBAL CELL SOLUTIONS INC
  • 9.9 NANOFIBER SOLUTIONS INCORPORATION
  • 9.10 INSPHERO AG
  • 9.11 LONZA GROUP
  • 9.12 NANO 3D BIOSCIENCES

10. FUTURE OUTLOOK OF THE MARKET

Back to Top